Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
John Milligan
Pharma
Gilead's ex-CEO racked up $26M in pay, severance for 2018
Gilead CEO John Milligan racked up $26M in 2018 pay, on paper at least, while incoming chief Daniel O'Day is in line for a cool $30M this year.
Tracy Staton
Mar 18, 2019 12:27pm
Gilead's HIV portfolio soars, but can it make up for HCV losses?
Oct 26, 2018 10:53am
Celgene veteran Fouse top pick for Gilead CEO: analyst
Jul 31, 2018 11:00am
Gilead's top execs Milligan and Martin stepping down
Jul 25, 2018 5:01pm
Growth-stymied Gilead promotes dealmaker to top strategy post
Jun 5, 2018 12:21pm
With hep C still under fire, Gilead's bottoming out
May 2, 2018 11:41am
